Propanc Biopharma (PPCB) Net Equity Issued and Repurchased (2011 - 2026)
Propanc Biopharma (PPCB) posted Net Equity Issued and Repurchased of $2.81 million for fiscal Q4 2026 (quarter ended Jun 30, 2026).
Powered by 
Analysis
Propanc Biopharma (PPCB) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Propanc Biopharma's Net Equity Issued and Repurchased came in at $3.31 million.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 33.7% (FY2021 to FY2026).
- In prior fiscal years, Propanc Biopharma's Net Equity Issued and Repurchased was $23,057 in FY2024 (-95.1%), $475,000 in FY2023 (-24.0%) and $625,001 in FY2022 (-19.5%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since fiscal Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | 2.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.81 Mn |
| Sep 30, 2025 | 3.31 Mn |
| Jun 30, 2024 | 11,975.00 |
| Mar 31, 2024 | -310,165.00 |
| Dec 31, 2023 | 92,057.00 |
| Sep 30, 2023 | 229,190.00 |
| Jun 30, 2023 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 99,285.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 275,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 325,000.00 |
| Sep 30, 2020 | 201,044.00 |
| Jun 30, 2019 | 68,401.00 |
| Mar 31, 2019 | 626,206.00 |
| Dec 31, 2018 | 405,743.00 |
| Sep 30, 2018 | 30.00 |
| Mar 31, 2017 | 1.00 |
API Access
Propanc Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();